InBios Obtains BARDA Funding to Develop Point of Care COVID-19 Test

InBios Awarded Contract from BARDA for COVID-19 Rapid Test

InBios receives FDA Emergency Use Authorization for its Smart Detect SARS-CoV-2 rRT-PCR Kit for Detection of the Virus causing COVID-19

InBios Gets FDA Emergency Use Authorization for SARS-CoV-2 Kit

Amid Coronavirus Outbreak, FDA and Industry Seek Roadmap

Evaluation of Chagas RDTs Shows High Accuracy in Endemic Region

FDA Approves Diagnostic Test for Zika Virus

Seattle's InBios: First to Receive FDA Authorization for Zika Test

First Diagnostic Test for Zika Gets FDA's OK to Market